A new publication from Scipher Medicine in the Journal of Molecular Diagnostics details new approach to discover treatment-response-predicting biomarkers for complex diseases. #biomarkerdiscovery #networkmedicine https://lnkd.in/gpfCNwDZ
Scipher Medicine
Biotechnology Research
Waltham, Massachusetts 27,220 followers
Scipher Medicine is a precision immunology company matching each patient with their most effective therapy.
Über uns
Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don’t respond to the treatment, costing the health care industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A simple test predicts which drug he/she will respond to, ensuring that most optimal treatment is prescribed from day one. The molecular data generated by our tests is then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.
- Website
-
https://www.sciphermedicine.com
External link for Scipher Medicine
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 51-200 Mitarbeiter
- Hauptsitz
- Waltham, Massachusetts
- Typ
- In Privatbesitz
- Gegründet
- 2015
- Spezialitäten
- network science, network medicine, data science, diagnostics, drug response prediction, drug development, complex diseases, autoimmune diseases, biomarkers, machine learning, gene expression, rheumatoid arthritis, IBD, ulcerative colitis, and precision medicine
Standorte
-
Primäre
Wegbeschreibung erhalten
500 Totten Pond Rd
Waltham, Massachusetts 02451, US
Employees at Scipher Medicine
Aktualisierungen
-
This week Scipher Medicine presented at EULAR 2024 in Vienna, Austria. The technology behind PrismRA and the impact that the test is having on treatment selection in RA is pushing precision medicine forward for autoimmune patients. #PrecisionMedicine #AutoimmuneDisease #RheumatoidArthritis https://lnkd.in/gFGtqTRg
Scipher Medicine® Showcases New Data at EULAR 2024
https://www.sciphermedicine.com
-
Scipher’s CEO & President, Reginald Seeto, CTO, Slava Akmaev, and Ingo Chakravarty are looking forward to joining over 500 public & private healthcare companies, investors, and VCs at this year’s Jefferies Global Healthcare Conference. #JefferiesHealthcare #PrecisionMedicine
-
-
Join us at BIO 2024 June 3-6 in San Diego, CA where Scipher’s executive leadership team will be meeting with leaders across the industry to showcase our unique Spectra Platform and the invaluable strides its making in precision medicine. #BIO2024 #PrecisionMedicine
-
-
This week Scipher’s own Uday Shankar Shanthamallu presented a poster at Digestive Disease Week in Washington DC. The research behind this poster continues to bring Scipher’s unique intelligence to precision medicine for treatment of autoimmune diseases such as Ulcerative Colitis. #PrecisonMedicine #AutoimmuneDisease #DDW2024 #ulcerativecolitis Link: https://lnkd.in/gb2smyT5
Identifying TNFI Therapy Response in UC Patients Using Baseline Whole Blood Gene Expression Data
https://www.sciphermedicine.com
-
Scipher Medicine is a precision immunology company on a mission to match each patient with their most effective therapy and bring forward the day when every autoimmune disease patient reaches remission, and no one suffers in silence. #ScipherMedicine #PrecisionMedicine #AutoimmuneDisease
-
-
Scipher Medicine reposted this
Our own, Sherry Guardiano, DO, MBA, presented an abstract at the Congress of Clinical Rheumatology conference in Destin, FL on Friday. PrismRA is proving its value in the rheumatology community as a keystone precision medicine test, guiding RA treatment decisions to get more patients to low disease activity or remission, sooner. #precisionmedicine #autoimmunedisease #rheumatoidarthritis
-
-
Scipher Medicine is proud to welcome Reginald Seeto as our new President and CEO. His unique background and vision for the future are the perfect combination for Scipher’s next phase of growth. Welcome Reg! https://lnkd.in/ggwuDWHG #precisionmedicine #autoimmunedisease #transformation #leadership
Dr. Reginald Seeto Appointed as CEO and President, to Lead Scipher Medicine’s Next Phase of Growth
https://www.sciphermedicine.com
-
Today we are launching an updated look & feel for Scipher Medicine. The brighter color pallet aligns with our vision of hope and using our network science to help those who are suffering in silence. #ScipherMedicine #PrecisionMedicine #AutoimmuneDisease #BrandRefresh
-
-
Autoimmune Awareness Month is an opportunity to shine a light on those affected by diseases where one’s immune system is attacking their own body. Scipher Medicine® is proud to be working for a better future for these patients and using advanced precision medicine science to help match each patient with their most effective therapy. #precisionmedicine #autoimmunedisease #awareness
-